|Day Low/High||59.45 / 62.46|
|52 Wk Low/High||11.54 / 87.00|
What if the market is simply pricing in a quarter that had already been priced out?
I would wait until the next down day, and there will be one.
Plus, a closer look at Thursday's late-day rally and at actions impacting the nation's big banks.
The charts of the electric vehicle maker are showing some weakening in the stock, though a major shake-out isn't likely.
Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?
I can't educate the foreign investors. The professional mutual fund managers think I'm dead wrong. But I can help teach the new retail traders.
This market is offering trading opportunities the likes of which haven't been seen since early 2009.
The massive tock market drop was to be expected, and seasoned traders were prepared for it. But there was also some good news on the coronavirus vaccine/treatment front.
The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.
Let's hope that the violence subsides, the valid voices of peaceful protesters are heard, and the lack of social distancing protocols does not lead to a resurgence in the spread of the virus.
A now-overbought market leaves few values available among equities.
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.
So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.
The negatives are being shaken off like a first time rider on a long-time bull which means long remains the name of the game.
I've been long Merck for a long time, since way before this pandemic became part of our lives.
The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.
The market may be down but, once again, the decline's about the White House getting re-tough on China.
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
Bull and bear markets are occurring simultaneously and that makes for good stock-picking but great difficulty if you are trying to trade the major indices.
Expect more fiscal and monetary support and don't expect a full return to previous economic activity for quite some time.
Headlines questioning phase-one trial data by Moderna spurred late selling as this market is still a bear.
So, let me get this straight. Moderna rushes to do a secondary last night even though they don't need the money yet. To me, if the vaccine works and they need to produce it in quantity, the stock will be many multiples higher than today -- and there...
Remarkable story about the vaccine czar and Moderna .
* I don't yearn or expect another yesterday, today. * Let it be... "Yesterday All my troubles seemed so far away Now it looks as though they're here to stay Oh, I believe in yesterday Suddenly I'm not half the man I used to be There's a shadow hangi...
Watching Moderna, Microsoft and FedEx as risk continues to be a central market theme, despite Monday's rally.
Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.